These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12297345)

  • 1. CTLA-4 upregulation during aging.
    Leng Q; Bentwich Z; Borkow G
    Mech Ageing Dev; 2002 Jul; 123(10):1419-21. PubMed ID: 12297345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention.
    Leng Q; Bentwich Z; Magen E; Kalinkovich A; Borkow G
    AIDS; 2002 Mar; 16(4):519-29. PubMed ID: 11872994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28, CTLA-4 and their ligands: who does what and to whom?
    Sansom DM
    Immunology; 2000 Oct; 101(2):169-77. PubMed ID: 11012769
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence.
    Wang XB; Kakoulidou M; Giscombe R; Qiu Q; Huang D; Pirskanen R; Lefvert AK
    J Neuroimmunol; 2002 Sep; 130(1-2):224-32. PubMed ID: 12225905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complexity of the B7-CD28/CTLA-4 costimulatory pathway.
    Schweitzer AN; Sharpe AH
    Agents Actions Suppl; 1998; 49():33-43. PubMed ID: 9426826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulatory regulation of T cell function.
    Chambers CA; Allison JP
    Curr Opin Cell Biol; 1999 Apr; 11(2):203-10. PubMed ID: 10209159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-stimulation in T cell responses.
    Chambers CA; Allison JP
    Curr Opin Immunol; 1997 Jun; 9(3):396-404. PubMed ID: 9203422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Yin and Yang of T cell costimulation.
    Allison JP; Krummel MF
    Science; 1995 Nov; 270(5238):932-3. PubMed ID: 7481795
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule.
    Riley JL; Schlienger K; Blair PJ; Carreno B; Craighead N; Kim D; Carroll RG; June CH
    J Exp Med; 2000 Jun; 191(11):1987-97. PubMed ID: 10839813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease.
    Karandikar NJ; Vanderlugt CL; Bluestone JA; Miller SD
    J Neuroimmunol; 1998 Aug; 89(1-2):10-8. PubMed ID: 9726820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells: A proliferation of costimulatory molecules.
    Mueller DL
    Curr Biol; 2000 Mar; 10(6):R227-30. PubMed ID: 10744968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
    Krummel MF; Allison JP
    J Exp Med; 1996 Jun; 183(6):2533-40. PubMed ID: 8676074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
    Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CTLA-4 in the regulation of T cell immune responses.
    McCoy KD; Le Gros G
    Immunol Cell Biol; 1999 Feb; 77(1):1-10. PubMed ID: 10101680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ups and downs of T cell costimulation.
    Jenkins MK
    Immunity; 1994 Sep; 1(6):443-6. PubMed ID: 7534615
    [No Abstract]   [Full Text] [Related]  

  • 19. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 can function as a negative regulator of T cell activation.
    Walunas TL; Lenschow DJ; Bakker CY; Linsley PS; Freeman GJ; Green JM; Thompson CB; Bluestone JA
    Immunity; 1994 Aug; 1(5):405-13. PubMed ID: 7882171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.